Clinical Trial Update: GSK2983559 First Time in Human Study [Phase 1]

View source ↗

Summary

Phase 1 first-in-human study of GSK2983559 in inflammatory bowel diseases was terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease

Drugs mentioned

• GSK2983559

Snippet

Sponsor: GlaxoSmithKline | Conditions: Inflammatory Bowel Diseases | Phase 1 | Status: TERMINATED | Results posted: 2020-06-22